OpenAI launches as a nonprofit AI lab
Musk, Sam Altman, Greg Brockman, Ilya Sutskever, and others frame the project around building advanced AI for broad human benefit.

The trial is the public record for a decade-long break between OpenAI's nonprofit origin story and the commercial AI arms race it helped create.
Musk argues OpenAI and its leaders abandoned a nonprofit, public-benefit mission while OpenAI argues Musk is using litigation to hurt a direct xAI competitor. The trial is one of the cleanest public records of how OpenAI changed from a donor-backed lab into a commercial AI power.
Musk, Sam Altman, Greg Brockman, Ilya Sutskever, and others frame the project around building advanced AI for broad human benefit.
The relationship fractures as OpenAI debates funding, control, safety, and how to compete with well-capitalized AI labs.
OpenAI creates a capped-profit structure, deepens its Microsoft relationship, launches ChatGPT, and becomes the central company in the generative AI boom.
Musk files litigation alleging OpenAI broke founding commitments by prioritizing profit and commercial exclusivity over the original mission.
Judge Yvonne Gonzalez Rogers confirms the April trial schedule, time limits, witness rules, and remedy disputes.
Reuters reported that Musk testified for more than seven hours over three days, presenting the case as a defense of charitable giving and OpenAI's original mission.
Reuters reported testimony from Mira Murati and others about internal conflicts, ChatGPT release concerns, executive trust, and governance.
Did OpenAI's founding documents and representations create enforceable promises about nonprofit control and public benefit?
Did OpenAI's commercial structure preserve the mission, or invert it by making the nonprofit secondary to the for-profit business?
What did Musk know about OpenAI's for-profit plans, Microsoft relationship, and governance changes before suing?
Can a remedy benefit OpenAI's nonprofit arm without benefiting Musk, xAI, or a Musk-controlled fund?
How much of the dispute is about AI safety, and how much is about control of the most valuable AI company in the world?
Current trial framing and AI-risk context.
Murati testimony, damages figure, and current week-two testimony.
Trial date, daily schedule, and time allocations.
Disgorgement remedy and waiver issues.
Why the case matters for AI's public-benefit origin story.

Ask anything about Elon — companies, predictions, tweets, controversies, vehicles, family.